DNA Nanostructures as Smart Drug-Delivery Vehicles and Molecular Devices

Trends Biotechnol. 2015 Oct;33(10):586-594. doi: 10.1016/j.tibtech.2015.08.001.

Abstract

DNA molecules can be assembled into custom predesigned shapes via hybridization of sequence-complementary domains. The folded structures have high spatial addressability and a tremendous potential to serve as platforms and active components in a plethora of bionanotechnological applications. DNA is a truly programmable material, and its nanoscale engineering thus opens up numerous attractive possibilities to develop novel methods for therapeutics. The tailored molecular devices could be used in targeting cells and triggering the cellular actions in the biological environment. In this review we focus on the DNA-based assemblies - primarily DNA origami nanostructures - that could perform complex tasks in cells and serve as smart drug-delivery vehicles in, for example, cancer therapy, prodrug medication, and enzyme replacement therapy.

Keywords: DNA nanotechnology; DNA origami; biocomputing; biosensing; cell uptake; drug delivery; enzymatic payloads; immunostimulation; self-assembly.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Base Pairing
  • DNA / chemistry*
  • DNA / metabolism
  • Drug Delivery Systems / instrumentation
  • Drug Delivery Systems / methods*
  • Enzyme Replacement Therapy / methods
  • Humans
  • Nanostructures / chemistry*
  • Nanotechnology / instrumentation
  • Nanotechnology / methods*
  • Neoplasms / pathology
  • Neoplasms / therapy
  • Nucleic Acid Conformation
  • Signal Transduction
  • Sphingolipidoses / pathology
  • Sphingolipidoses / therapy

Substances

  • DNA